
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1012 | 1000 | 1064 | 1286 | 1646 | 2578 |
Fund Return | 1.18% | 0.02% | 6.41% | 8.75% | 10.48% | 9.93% |
Place in category | 1610 | 1623 | 1763 | 1143 | 847 | 111 |
% in Category | 85 | 85 | 97 | 75 | 65 | 19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Eq Cl Sr Adv | 7.56B | 1.00 | 7.44 | 8.45 | ||
Manulife Glbl Eq Cl Sr F | 7.56B | 1.20 | 8.76 | 9.80 | ||
Manulife Glbl Eq Cl Sr FT6 | 7.56B | 1.20 | 8.77 | 9.80 | ||
Manulife Glbl Eq Cl Sr T6 | 7.56B | 1.00 | 7.43 | 8.44 | ||
Manulife Div incm Fd Sr Adv | 6.9B | 1.45 | 6.72 | 8.42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 17.07B | -0.93 | 23.49 | - | ||
Capital Group Glbal Equity Fd F CAD | 13.5B | 2.07 | 11.83 | 10.97 | ||
Capital Group Glbal Equity Fd A CAD | 13.5B | 1.89 | 10.61 | 9.74 | ||
Capital Group Glbal Equity Fd D CAD | 13.5B | 2.03 | 11.47 | 10.50 | ||
EdgePoint Glbl Port non HST Sr A | 12.53B | 5.94 | 8.84 | 7.77 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.22 | 92.24 | +0.92% | |
Marsh McLennan | US5717481023 | 4.43 | 231.91 | +0.16% | |
Alphabet C | US02079K1079 | 4.15 | 166.45 | -0.70% | |
Microsoft | US5949181045 | 4.14 | 387.14 | -0.37% | |
UnitedHealth | US91324P1021 | 3.94 | 497.81 | +1.87% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review